Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
Interventional
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
To determine whether specific gene expression profiles are associated with response in oesophago-gastric cancer.
David Cunningham
Principal Investigator
Royal Marsden NHS Foundation Trust
United Kingdom: Medicines and Healthcare Products Regulatory Agency
2110
NCT00220077
June 2002
Name | Location |
---|